The Company's Distribution Agreement with Coapt
has been terminated, and the Company plans to directly distribute HYDRELLE in the interim while it determines its worldwide strategy for this product franchise.
Those interested in learning more about the COAPT
trial can call 858-554-5209.
During the third quarter, we also launched our aesthetics dermatology product, Hydrelle, in the United States through our exclusive distribution partner, Coapt
Systems," Sherwood said.
clinical trials and the filing of a PMA, and its expectations to reap significant financial rewards for moving the product through the pipeline, (ii) expectations regarding Coapt
Systems including timing to begin selling Hydrelle, (iii) statements concerning revenue and income performance in 2009, and (iv) expectations that Anika's investments will result in accelerated growth in 2010 and beyond.
distribution agreement with Palo Alto, California-based Coapt
Systems Executive Vice President, Global Marketing and Sales, David Barella stated, "The Coapt
Systems sales and marketing team is delighted to introduce Hydrelle to the facial aesthetic community throughout the U.
Byron and Coapt
are best described as "Cutting Edge".
Other recent Canaan healthcare investments include Chimerix, Coapt
, CoAxia and Northstar Neuroscience (NSTR).
David Apfelberg, Medical Director for Coapt
Systems, "Examples of patients who can be helped by Novielle Voice injections are patients who have experienced damage to nerves in the voice box, stroke, or surgery of the esophagus.
Companies detailed include Aesthera, Aesthetic Solutions, Aesthetic Technologies, Allergan, Alma Lasers, Anika Therapeutics, Artes Medical, BioForm Medical, Candela, Coapt
Systems, Cutera, Cynosure, Dermik Laboratories/Sanofi-Aventis, Dynatronics, Edge Systems, Inamed/Allergan, IRIDEX, LipoSonix, Lumenis, Medicis, MediCor, Mentor, Merz Pharmaceuticals, MicroAire Surgical, Palomar Medical Technologies, Prollenium Medical Technologies, Reliant Technologies, ReVance Therapeutics, Rhytec, Silimed, Sound Surgical Technologies, Surgical Specialties/Angiotech Pharmaceuticals, Syneron Medical, Thermage, Ulthera, UltraShape, and Wells Johnson, among many others.
Their proven track records, strategic leadership and industry knowledge will be invaluable to us as we continue our growth into new technologies, including non-invasive opportunities," commented Laureen DeBuono, President and Chief Executive Officer of Coapt
Foundation was an early venture investor in now-public companies AtriCure (NASDAQ:ATRC), Combinatorx (NASDAQ:CRXX), Immunicon (NASDAQ:IMMC), and Northstar Neuroscience (NASDAQ:NSTR), as well as a portfolio of other privately held firms, such as BioNeuronics, BridgePoint Medical, CoApt
Systems, CardioNet, CardioMEMS, EndoGastric Solutions, Marinus Pharmaceuticals, and SpineWave.